Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force

R Chou, A Cantor, T Dana, J Wagner, AY Ahmed, R Fu… - Jama, 2022 - jamanetwork.com
Importance A 2016 review for the US Preventive Services Task Force (USPSTF) found use
of statins for primary prevention of cardiovascular disease (CVD) was associated with …

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta …

T Cai, L Abel, O Langford, G Monaghan, JK Aronson… - Bmj, 2021 - bmj.com
Objective To assess the associations between statins and adverse events in primary
prevention of cardiovascular disease and to examine how the associations vary by type and …

Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients

P Willeit, L Tschiderer, E Allara, K Reuber… - Circulation, 2020 - Am Heart Assoc
Background: To quantify the association between effects of interventions on carotid intima-
media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk …

Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force

R Chou, T Dana, I Blazina, M Daeges, TL Jeanne - Jama, 2016 - jamanetwork.com
Importance Cardiovascular disease (CVD), the leading cause of mortality and morbidity in
the United States, may be potentially preventable with statin therapy. Objective To …

Statins for the primary prevention of cardiovascular disease

F Taylor, K Ward, THM Moore, M Burke… - Cochrane database …, 2011 - cochranelibrary.com
Background Reducing high blood cholesterol, a risk factor for cardiovascular disease (CVD)
events in people with and without a past history of coronary heart disease (CHD) is an …

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial

SM Harman, DM Black, F Naftolin… - Annals of internal …, 2014 - acpjournals.org
Background: Whether menopausal hormone therapy (MHT) protects against cardiovascular
disease (CVD) remains unclear. Objective: To assess atherosclerosis progression and CVD …

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

JJ Brugts, T Yetgin, SE Hoeks, AM Gotto, J Shepherd… - Bmj, 2009 - bmj.com
Objectives To investigate whether statins reduce all cause mortality and major coronary and
cerebrovascular events in people without established cardiovascular disease but with …

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis

D Bassler, M Briel, VM Montori, M Lane, P Glasziou… - Jama, 2010 - jamanetwork.com
Context Theory and simulation suggest that randomized controlled trials (RCTs) stopped
early for benefit (truncated RCTs) systematically overestimate treatment effects for the …

American Society of Echocardiography recommendations for use of echocardiography in clinical trials: a report from the american society of echocardiography's …

JS Gottdiener, J Bednarz, R Devereux… - Journal of the …, 2004 - onlinejase.com
Echocardiography is one of the most commonly performed noninvasive diagnostic tests in
patients with known or suspected cardiovascular diseases. Echocardiography provides …

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

JC LaRosa, J He, S Vupputuri - Jama, 1999 - jamanetwork.com
ContextLowering low-density lipoprotein cholesterol (LDL-C) is known to reduce risk of
recurrent coronary heart disease in middle-aged men. However, this effect has been …